Search research articles
Contact Us
Filters
Showing results (301-310 of 386) with videos related to
Page
of 39
Sort By:
Neuro-Oncology
|
February 23, 2011
DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression
Shichun Zheng, E Andres Houseman, Zachary Morrison, et al.
The Lancet. Oncology
|
October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the art
Benjamin H Kann, Arastoo Vossough, Sarah C Brüningk, et al.
Neuro-Oncology
|
January 29, 2014
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Patrick Y Wen, Susan M Chang, Kathleen R Lamborn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2026
A genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastoma
Jiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky, et al.
AJNR. American Journal of Neuroradiology
|
December 8, 2025
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical Applications
Ali Nabavizadeh, Kazim Narsinh, Timothy J Kaufmann, et al.
Neuro-Oncology Advances
|
December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
Jessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.
The Lancet. Oncology
|
November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
Philipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Neuro-Oncology
|
April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience
Eudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Neuro-Oncology
|
April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas
Yao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
The Lancet. Oncology
|
October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation
Anahita Fathi Kazerooni, Ariana M Familiar, Mariam Aboian, et al.
Page
of 39
Search research articles
Search
Showing results (301-310 of 386) with videos related to
Sort By:
Page
of 39
Neuro-Oncology
|
February 23, 2011
DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression
Shichun Zheng, E Andres Houseman, Zachary Morrison, et al.
The Lancet. Oncology
|
October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the art
Benjamin H Kann, Arastoo Vossough, Sarah C Brüningk, et al.
Neuro-Oncology
|
January 29, 2014
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Patrick Y Wen, Susan M Chang, Kathleen R Lamborn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2026
A genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastoma
Jiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky, et al.
AJNR. American Journal of Neuroradiology
|
December 8, 2025
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical Applications
Ali Nabavizadeh, Kazim Narsinh, Timothy J Kaufmann, et al.
Neuro-Oncology Advances
|
December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
Jessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.
The Lancet. Oncology
|
November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
Philipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Neuro-Oncology
|
April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience
Eudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Neuro-Oncology
|
April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas
Yao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
The Lancet. Oncology
|
October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation
Anahita Fathi Kazerooni, Ariana M Familiar, Mariam Aboian, et al.
Page
of 39